SCHOTT Pharmaversity™

Discover how prefilled syringes withstand ultra-cold storage from -80°C to -180°C without compromising integrity. Join our webinar to explore key insights on container closure integrity, silicone distribution, and mechanical performance—proven stable under extreme conditions. Learn about testing methods, critical data, and what this means for the future of cell and gene cold chain solutions. Learn...

When it comes to drug containment, not only the stability of the drug plays a crucial role, but also the stability of the container itself - an optimized geometry can help to avoid breakage, during fill-and-finish as well as during storage. Resulting in safeguarding the patient and improving efficiency. In addition, high rejections rates due to cosmetic defects or due to fogging during lyophilizat...

Good-quality pharmaceutical containers are not only a prerequisite for the safe storage and delivery of drug products, but they also have a positive impact on fill-and-finish processes. The more uniform a container is, the smoother it runs on the fill-and-finish line, resulting in lower container-related rejection rates. In this Pharmaversity session you will get insights on how you can unlock fil...

Prefilled polymer syringes have significantly enhanced the safety and effectiveness of infusion therapy in hospitals, moving away from traditional vial-and-syringe systems. Despite these advancements, hospitals still encounter various challenges, such as high drug waste due to unclear packaging, manual tray preparation, and storage issues. Additionally, pharmaceutical manufacturers face stringent...

Climate change stands as one of the most pressing challenges of our time, demanding innovative solutions to decarbonize production and supply chains globally. Over 7,000 companies, including 19 of the top 20 pharmaceutical firms, have committed to science-based targets to ensure a reliable and scientific approach to this issue. It's time to share a blueprint for drastically reducing emissions with...

The integrity of pharmaceutical packaging is vital, especially for biologics, where drug-container interactions can significantly impact stability and efficacy. In the upcoming webinar we will explore key considerations in selecting and optimizing ready-to-use (RTU) cartridges for complex drug formulations. Topics include material compatibility, leachable profiles, and strategies to mitigate risks...

The pharmaceutical industry continues to trend towards large volume subcutaneous drug formulations, accompanied by a strong emphasis on simplifying drug administration. However, dosage volumes of 10 mL and higher present specific challenges, including limited availability of qualified primary packaging, shortcomings in On Body Devices, and the drawbacks of manual push drug administration. The SCHO...

Despite advancements in subcutaneous (SC) autoinjection, comprehensive insights are still limited. SC delivery of biologics faces challenges such as drug volume, viscosity, and user injection time. While adjunct molecules have improved absorption for larger doses, significant gaps remain in SC drug development. Join this joint webinar by SHL Medical and SCHOTT Pharma, where we will present finding...

Primary packaging is a crucial component of drug formulation. Even the most advanced medication can lose its efficacy if stored in a container that fails to maintain its stability over time. With the growing prevalence of biologics, the range of molecules and applications continues to expand, leading to increasingly diverse requirements for primary packaging. For example, more than 50% of biologic...

The use of biologics is a rapidly growing field in the treatment of chronic diseases, both in hospitals and through patient self-medication at home. Pharma companies' development pipelines for injectable biologics are well-filled, projecting a high demand for high-end container solutions. These solutions must be robust and reliable to address the numerous challenges of biologics, such as drug-cont...

In pharmaceutical manufacturing, operational efficiency is crucial for meeting production targets while ensuring product quality and cost-effectiveness. One impactful strategy is increasing the number of cavities per nest for prefilable polymer syringes. This enhancement maximizes conveyor space utilization, streamlines production processes, and supports sustainability objectives by minimizing mat...

Latest innovations in drug technologies seek to bring cancer treatment to the next level. For example, using the targeting ability of monoclonal antibodies in combination with a cytotoxic (Antibody Drug Conjugates) or radioactive molecule (Radionuclide Drug Conjugates). These medicines offer a promising alternative to common radiation or chemotherapy, potentially increasing effectiveness and reduc...

Contamination control programming, as defined in EU Annex I, mitigates risk. This webinar highlights elements of the SCHOTT Pharma Contamination Control Strategy (CCS) and strategies for compliance with GMP standards. Integrating RTU containers with state-of-the-art filling concepts minimizes contamination risks, streamers validation processes, and enhances overall manufacturing efficiency. Compli...

The road to drug submission can feel like an existential question through a labyrinth with a blindfold—exciting yet slightly terrifying. This webinar will delve into the complexities of drug submission, illuminating the path with insights into Testing Services for Combination Drug Products. Gain insights on streamlining your testing processes for regulatory compliance, accelerating your market sub...

mRNA. saRNA. DNA drugs. Only some of the groundbreaking medical developments that offer new possibilities for treating different diseases. The stability of these biological drugs, until they are injected, is mainly achieved with storage at deep-cold temperatures. This brings several significant challenges for pharmaceutical companies. This webinar will explore the complexities of deep-cold require...

Larger subcutaneous injections are becoming more prominent due to recent advances in formulation development and new therapeutic areas. Therefore, novel large volume autoinjectors need to be developed to fulfill this new demand. As the interplay of device and container is crucial for a safe and reliable drug administration, a co-development between container and device manufacturers is a meaningfu...

A growing number of drugs like gene therapies, mRNA-, DNA- and viral vector vaccines require storage at deep cold temperatures. The functionality of the primary packaging is strongly impacted at these temperatures and limited market know-how is available. In this Pharmaversity™ session our experts will provide insight in how low temperature storage can influence the primary packaging and a science...

During pharma development, goal number one is to find a formulation that keeps the drug stable and hence safe for the future patient. The more formulation options you have, the higher the likelihood that you find the most appropriate solution for the specific drug along its life cycle. Later re-formulations due to stability issues as e.g. particle formation or pH shift are time- and cost intensive...

A growing number of drugs like gene therapies, mRNA-, DNA- and viral vector vaccines require storage down to – 80 °C.At these low temperatures the vial behavior may be impacted in a way that flaws in combination with thermal stresses can lead to an increased risk of breakage although glass is thermally stable. Another question arising is if container closure integrity (CCI) is stable under these c...

Las ampollas fueron el primer contenedor desarrollado para almacenar medicamentos inyectables. Todavía hoy es el contenedor más utilizado a nivel mundial contribuyendo a salvar vidas en todo el mundo. Aprenda en este webinar cómo mejorar el proceso de llenado y obtenga información sobre cómo hacer frente a los desafíos comunes asociados con el procesamiento y manipulación de ampollas. Desde la per...

It is crucial to reliably evaluate the effect of bulk fill-and-finish processing on cosmetic as well as on strength-affecting defects. Unfortunately, it requires a high effort to perform a dedicated line trial to assess different vial features, which is of particular interest during product development. Due to this challenge, a laboratory method has been designed in order to generate characteristi...

Pharmaceutical companies are continuously evaluating the efficiency of their filling lines to achieve lower costs, better quality and higher flexibility. Three slightly contradictory goals require a fundamental rethinking of manufacturing processes. This session addresses the core challenges and how ready-to-use (RTU) vials like adaptiQ® from SCHOTT Pharma can help to improve the drug quality and...

The combination of YpsoDose and the 10 mL cartriQ® shows how innovative capabilities and expertise can address perfect fit for use, efficient processing as well as safe and easy administration for injectable medication. SCHOTT Pharma’s expertise in drug containment and delivery solutions and Ypsomed’s expertise in injection systems make them the ideal partners to present their joint solution in th...

Providing lifesaving treatment is daily business for hospitals. However, the hospital setting is a notorious hectic place with drug shortages and inefficient and labor intensive steps as possible reasons for poorer patient care. Prefilled syringes (PFS) help in accelerate the drug administration process and reduce the medical errors, but more can be gained with equipping the PFS with RFID.  Learn...

Today, most companies are aware of the need for future climate-neutral or net-zero pharmaceutical products. But, the question is how to get there. Our response is industry collaboration: With our partners in the Alliance to Zero we are conceptionalizing how the product carbon footprint of autoinjectors can be mitigated. With this presentation, we take you with us on the journey to zero: starting f...